Emergent Biosolutions, Inc. (EBS) Revenue by Year
Emergent Biosolutions, Inc. generated $742.9M in revenue in fiscal year 2025. This represents a decrease of 28.8% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $770.2M in revenue. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Emergent Biosolutions, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
EBS Revenue by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | TTM | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $770.2M | $742.9M-28.8% | $1.0B-0.5% | $1.0B-6.1% | $1.1B-37.0% | $1.8B+12.4% | $1.6B+42.6% | $1.1B+41.4% | $782.4M+39.5% | $560.9M+14.8% | $488.8M-6.5% | $522.8M+16.1% | $450.1M+43.9% | $312.7M+10.9% | $281.9M+3.1% | $273.4M |
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
EBS Revenue by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What revenue means
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.
More Emergent Biosolutions, Inc. financials
Frequently Asked Questions
What was Emergent Biosolutions, Inc.'s revenue in fiscal year 2025?
Emergent Biosolutions, Inc. generated $742.9M in revenue in fiscal year 2025.
How fast is Emergent Biosolutions, Inc.'s revenue growing?
Emergent Biosolutions, Inc. (EBS) revenue fell by 28.8% year over year, from $1.0B to $742.9M in fiscal year 2025.
What is Emergent Biosolutions, Inc.'s revenue over the last twelve months?
Emergent Biosolutions, Inc. (EBS) reported $770.2M in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has Emergent Biosolutions, Inc.'s revenue changed over the years?
Across the 15 fiscal years this page covers, Emergent Biosolutions, Inc. (EBS) revenue went from $273.4M in fiscal year 2011 to $742.9M in fiscal year 2025.
What was Emergent Biosolutions, Inc.'s revenue in the most recent quarter?
Emergent Biosolutions, Inc. (EBS) reported $234.3M in revenue in Q2 2026. This represents an increase of 66.3% from the same quarter a year earlier.
What does revenue mean on a financial statement?
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Emergent Biosolutions, Inc. (EBS) reported on that line in every period on record.